1. Home >
  2. M&A >
  3. Divestiture >
  4. MediS Group Acquires Winthrop Pharma Senegal

M&A Deal Summary

MediS Group Acquires Winthrop Pharma Senegal

On April 19, 2017, MediS Group acquired life science company Winthrop Pharma Senegal from Sanofi

Acquisition Highlights
  • This is MediS Group’s 1st transaction in the Life Science sector.
  • This is MediS Group’s 1st transaction in Senegal.

M&A Deal Summary
Date 2017-04-19
Target Winthrop Pharma Senegal
Sector Life Science
Buyer(s) MediS Group
Sellers(s) Sanofi
Deal Type Divestiture

Target

Winthrop Pharma Senegal

Dakar, Senegal
WPS is a significant operator in the pharmaceuticals sector in French-speaking sub-Saharan Africa (FSSA). MédiS' acquisition includes a 34,000m² manufacturing facility in the Rufisque district of Dakar, Senegal.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MediS Group

Nabeul, Tunisia
Category Company
Founded 1995
Sector Life Science
DESCRIPTION

MediS Group is a branded generic pharmaceutical company operating in Tunisia and Algeria. It manufactures a broad portfolio of affordable medicines trusted by doctors and patients, spanning therapeutic areas such as cardiology, diabetology, neuropsychiatry, oncology, pain, allergies, and gastroenterology. MediS also develops and markets advanced treatments, including biosimilars for conditions like deep vein thrombosis, pulmonary embolism, infertility, and multiple sclerosis. MediS Group was founded in 1995 and is based in Nabeul, Tunisia.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Senegal M&A 1 of 1
Year: 2017 M&A 1 of 1

Seller(S) 1

SELLER

Sanofi

Paris, France
Category Company
Founded 1994
Sector Life Science
Employees82,878
Revenue 44.3B EUR (2024)
DESCRIPTION

Sanofi is a French multinational pharmaceutical company. Sanofi was founded in 1994 and is based in Paris, France.

DEAL STATS #
Overall 6 of 15
Sector: Life Science M&A 4 of 8
Type: Divestiture M&A Deals 6 of 15
Country: Senegal M&A 1 of 1
Year: 2017 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-13 Sanofi SA - Consumer Healthcare Products

Paris, France

Sanofi SA - Consumer Healthcare Products includes Prontalgine®, an analgesic for the treatment of moderate to severe pain, which has grown at double digit rates over the last four years and is available only in France. The portfolio also includes Buscopan®2, an antispasmodic; Suppositoria Glycerini3, a laxative; and Mucothiol® and Mucodyne®4, expectorants for cough and flu.

Sell €83M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-22 Bioverativ

Waltham, Massachusetts, United States

Bioverativ, Inc. is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies.

Buy $11.6B
Mergr

Solution for

Product

Company

Legal